Distinguishing Between a Drug Side Effect and a UC Flare One of the trickiest parts of taking a GLP-1 for people with UC is determining whether new symptoms are due to the medication or the disease flaring
Summary: Mounjaro (tirzepatide) does not directly lower potassium levels, and hypokalaemia is not a recognised adverse effect in clinical trials or regulatory guidance
Most importantly, they allow the compounder to create specialized/customized vehicles with adjusted strengths, which opens up more treatment options for our patients
These foods are often harder to digest, which can make you even more queasy while taking Mounjaro
Dysesthesia (tingling, numbness) at higher retatrutide doses
This tripeptide, made of cysteine, glutamate, and glycine, plays an essential role in cellular processes